-
Ondansetron Injection USP
SteriMax is pleased to announce the launch of Ondansetron 8 mg / 4 mL (2 mg / mL). To learn more visit the Ondansetron product page. -
Ondansetron Injection USP
SteriMax is pleased to announce the launch of Ondansetron 4 mg/ 2 mL (2 mg / mL). To learn more visit the Ondansetron product page. -
Furosemide Injection USP
Furosemide Injection USP SteriMax is pleased to announce the launch of Furosemide for Injection. To learn more visit the Furosemide product page. -
Bupivacaine Hydrochloride in Dextrose Injection USP 0.75%
Bupivacaine Injection SteriMax is pleased to announce the launch of Bupivacaine Hydrochlorhide in Dextrose Injection USP. To learn more visit the Bupivacaine product page. -
Busulfan for Injection
SteriMax is pleased to announce the launch of Busulfan. To learn more visit the Busulfan product page. -
SteriMax New Product Acquisition
SteriMax is pleased to announce the acquisition of the following products from Valeant Canada effective December 1st, 2017. -
Furosemide for Injection
SteriMax is pleased to announce the launch of Furosemide for Injection. To learn more visit the Furosemide product page.
Search
Recent Posts
- SteriMax is pleased to announce the launch of Carmustine for Injection USP
- SteriMax is pleased to announce the launch of Thiotepa for Injection USP
- Importation of UK – Labelled ERWINASE for Injection to provide continued patient access to ERWINASE Injection
- Available Now – Importation of UK-labelled Magnesium Sulfate 50% w/v Solution for Injection
- SteriMax is pleased to announce the launch of Levetiracetam for Levetiracetam Injection USP